Home - Medical Policies - Alabama
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HealthSmartRx Smart RxAssist Program
- Hemophilia Drugs
- Medical Policies
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Hemophilia Drug Pilot - PEEHIP Members Only
Effective February 1, 2019, Blue Cross and Blue Shield of Alabama implemented a pilot program for members with hemophilia covered under Public Education Employee Health Insurance (PEEHIP). This program applies only to PEEHIP members with contract prefix EDU, group number 14000.
As part of this program:
- Hemophilia factor replacement products will require prior authorization according to the policies listed under Final Hemophilia Drug Policies.
- All hemophilia factor replacement products will be required to be dispensed through Option Care Specialty Pharmacy only.
- Prior to each dispense of hemophilia factor replacement products, a dose authorization will be required to ensure appropriate assay management, inventory management, and patient engagement is being provided. Option Care will work with members to complete information required for this authorization.
Fax completed PEEHIP Prior Authorization Request Form for PEEHIP members only to 1-866-606-6021. Prescribers and Specialty Pharmacies should not use this form for any members without contract prefix EDU to prevent delays in obtaining a PA.
Fax prescriptions for hemophilia factor replacement products to Option Care at 1-205-982-9408.
For general program information, call 1-401-344-1021.
Node: bclrgrpappp1001.corp.bcbsal.org:8080